Pfizer Inc, New York, New York (Dr Chung); Pfizer Inc, Groton, Connecticut (Mr Calcagni, Dr Glue); and Pfizer Global Research and Development, Clinical Research Unit, Ann Arbor, Michigan (Dr Bramson). Financial support for this study was provided by Pfizer Inc.
Address for correspondence: Candace Bramson, MD, Pfizer Global Research and Development, Ann Arbor Laboratories, 2800 Plymouth Road, Ann Arbor, MI 48105; e-mail: [email protected].
This study was conducted at Pfizer Global Research and Development, Clinical Research Unit, Ann Arbor, Michigan, and it was approved by Pfizer Research Clinic Institutional Review Board, Ann Arbor, Michigan. All authors were or are currently employees of Pfizer Inc.
The data derived herein were presented in part at the XIII International Symposium on Atherosclerosis, September 28, 2003, Kyoto, Japan.
Submitted for publication December 29, 2005; revised version accepted May 23,2006.
